IL6 and COVID-19: In conclusion, our study for the first time provides evidence that in patients with severe COVID‐19 and high‐grade systemic inflammation, circulating IL‐6 elevation is associated with a significant delay of AV conduction, independent of concomitant confounding factors but synergistically operating with them.